Observation
Observation is an intervention with 405 clinical trials. Currently 91 active trials ongoing. Historical success rate of 89.0%.
Success Metrics
Based on 186 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
28
Mid Stage
33
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.3%
186 of 213 finished
12.7%
27 ended early
91
trials recruiting
405
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study
Observational Approach Versus Surgical Intervention for Stones
Early Life Exposures Among Children With Sickle Cell Disease
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
Clinical Trials (405)
Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory Study
Observational Approach Versus Surgical Intervention for Stones
Early Life Exposures Among Children With Sickle Cell Disease
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Fecal Microbiome Signature of Multi-Strain Probiotics Supplementation in Children and Adolescents With Inflammatory Bowel Disease
A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients
Observation Alone for Mild Non-Lactational Mastitis
Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Home Environmental Risks and Caregiver Awareness
Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Predictors of Transmural Non-Occlusive Mesenteric Ischemia in ICU Patients With Suspected Acute Mesenteric Ischemia
Gut Microbiome in AP Naive
Identifying and Treating Depression in the Orthopaedic Trauma Population
Genetic Study of Amyotrophic Lateral Sclerosis in Norway
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 405